GC-MS Based Phytochemical Profiling and Integrated In vitro and In silico Evaluation of Cucurbita maxima Leaf Extract Against Diabetes and Androgen Receptor Dependent Prostate Cancer
This study demonstrates that *Cucurbita maxima* leaf extract exhibits concentration-dependent α-amylase inhibitory activity and identifies Stigmasterol (CMP88) and Desmosterol (CMP91) as promising dual-target candidates for diabetes and androgen receptor-dependent prostate cancer through integrated *in vitro* assays and *in silico* molecular docking and dynamics simulations.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.